Company Search:
Advanced Search
Sponsored Links
FUREN Group Pharmaceutical Co Ltd Company Snapshot
FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other companies in this sector in China: Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2018 sales of 6.36 billion Chinese Renmimbi [US$950.74 million] ), Hubei Jumpcan Pharmaceutical Co Ltd (7.08 billion Chinese Renmimbi [US$1.06 billion] ), and China Medical System Holdings Limited (5.43 billion Chinese Renmimbi [US$812.41 million] of which 100% was Pharmaceutical Products).

Sales Analysis. FUREN Group Pharmaceutical Co Ltd reported sales of 6.23 billion Chinese Renmimbi (US$932.04 million) for the year ending December of 2018. This represents an increase of 7.5% versus 2017, when the company's sales were 5.80 billion Chinese Renmimbi. Sales at FUREN Group Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 1,497%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
FUREN Group Pharmaceutical Co Ltd
  Stock Performance Chart for FUREN Group Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 16.63
(Figures in Chinese Renmimbi)
1 Week 1.4%   13 Weeks 9.7%  
4 Weeks 29.6%   52 Weeks -11.6%  
FUREN Group Pharmaceutical Co Ltd Key Data:
  Ticker: 600781 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,233,518,546
(Year Ending Jan 2019).
Employees: 4,331
  Currency: Chinese Renmimbi Market Cap: 10,429,629,425
  Fiscal Yr Ends: December Shares Outstanding: 627,157,512
  Share Type: A Gu Closely Held Shares: 486,100,629
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.